Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia

Abstract Platinum‐based compounds in chemotherapy such as oxaliplatin often induce peripheral neuropathy and neuropathic pain such as cold allodynia in patients. Transient Receptor Potential Melastatin 8 (TRPM8) ion channel is a nociceptor critically involved in such pathological processes. Direct b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aerziguli Aierken, Ya‐Kai Xie, Wenqi Dong, Abuliken Apaer, Jia‐Jia Lin, Zihan Zhao, Shilong Yang, Zhen‐Zhong Xu, Fan Yang
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/6708c24e19d8497b9799498ae01517f0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6708c24e19d8497b9799498ae01517f0
record_format dspace
spelling oai:doaj.org-article:6708c24e19d8497b9799498ae01517f02021-11-17T08:40:31ZRational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia2198-384410.1002/advs.202101717https://doaj.org/article/6708c24e19d8497b9799498ae01517f02021-11-01T00:00:00Zhttps://doi.org/10.1002/advs.202101717https://doaj.org/toc/2198-3844Abstract Platinum‐based compounds in chemotherapy such as oxaliplatin often induce peripheral neuropathy and neuropathic pain such as cold allodynia in patients. Transient Receptor Potential Melastatin 8 (TRPM8) ion channel is a nociceptor critically involved in such pathological processes. Direct blockade of TRPM8 exhibits significant analgesic effects but also incurs severe side effects such as hypothermia. To selectively target TRPM8 channels against cold allodynia, a cyclic peptide DeC‐1.2 is de novo designed with the optimized hot‐spot centric approach. DeC‐1.2 modality specifically inhibited the ligand activation of TRPM8 but not the cold activation as measured in single‐channel patch clamp recordings. It is further demonstrated that DeC‐1.2 abolishes cold allodynia in oxaliplatin treated mice without altering body temperature, indicating DeC‐1.2 has the potential for further development as a novel analgesic against oxaliplatin‐induced neuropathic pain.Aerziguli AierkenYa‐Kai XieWenqi DongAbuliken ApaerJia‐Jia LinZihan ZhaoShilong YangZhen‐Zhong XuFan YangWileyarticledesigned proteinion channels, oxaliplatin‐induced cold allodyniapainTRPM8ScienceQENAdvanced Science, Vol 8, Iss 22, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic designed protein
ion channels, oxaliplatin‐induced cold allodynia
pain
TRPM8
Science
Q
spellingShingle designed protein
ion channels, oxaliplatin‐induced cold allodynia
pain
TRPM8
Science
Q
Aerziguli Aierken
Ya‐Kai Xie
Wenqi Dong
Abuliken Apaer
Jia‐Jia Lin
Zihan Zhao
Shilong Yang
Zhen‐Zhong Xu
Fan Yang
Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
description Abstract Platinum‐based compounds in chemotherapy such as oxaliplatin often induce peripheral neuropathy and neuropathic pain such as cold allodynia in patients. Transient Receptor Potential Melastatin 8 (TRPM8) ion channel is a nociceptor critically involved in such pathological processes. Direct blockade of TRPM8 exhibits significant analgesic effects but also incurs severe side effects such as hypothermia. To selectively target TRPM8 channels against cold allodynia, a cyclic peptide DeC‐1.2 is de novo designed with the optimized hot‐spot centric approach. DeC‐1.2 modality specifically inhibited the ligand activation of TRPM8 but not the cold activation as measured in single‐channel patch clamp recordings. It is further demonstrated that DeC‐1.2 abolishes cold allodynia in oxaliplatin treated mice without altering body temperature, indicating DeC‐1.2 has the potential for further development as a novel analgesic against oxaliplatin‐induced neuropathic pain.
format article
author Aerziguli Aierken
Ya‐Kai Xie
Wenqi Dong
Abuliken Apaer
Jia‐Jia Lin
Zihan Zhao
Shilong Yang
Zhen‐Zhong Xu
Fan Yang
author_facet Aerziguli Aierken
Ya‐Kai Xie
Wenqi Dong
Abuliken Apaer
Jia‐Jia Lin
Zihan Zhao
Shilong Yang
Zhen‐Zhong Xu
Fan Yang
author_sort Aerziguli Aierken
title Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
title_short Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
title_full Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
title_fullStr Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
title_full_unstemmed Rational Design of a Modality‐Specific Inhibitor of TRPM8 Channel against Oxaliplatin‐Induced Cold Allodynia
title_sort rational design of a modality‐specific inhibitor of trpm8 channel against oxaliplatin‐induced cold allodynia
publisher Wiley
publishDate 2021
url https://doaj.org/article/6708c24e19d8497b9799498ae01517f0
work_keys_str_mv AT aerziguliaierken rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
AT yakaixie rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
AT wenqidong rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
AT abulikenapaer rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
AT jiajialin rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
AT zihanzhao rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
AT shilongyang rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
AT zhenzhongxu rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
AT fanyang rationaldesignofamodalityspecificinhibitoroftrpm8channelagainstoxaliplatininducedcoldallodynia
_version_ 1718425675555143680